FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

789075005: Product containing cilastatin and imipenem and relebactam in parenteral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3786628017 Product containing cilastatin and imipenem and relebactam in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3786629013 Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3786628017 Product containing cilastatin and imipenem and relebactam in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3786629013 Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form Is a Cilastatin- and imipenem- and relebactam-containing product true Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form Plays role Antibacterial therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Relebactam (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Cilastatin true Inferred relationship Existential restriction modifier (core metadata concept) 3
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Imipenem true Inferred relationship Existential restriction modifier (core metadata concept) 1
Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form Is a Cilastatin- and imipenem-containing product in parenteral dose form true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Cilastatin and imipenem and relebactam only product in parenteral dose form Is a True Cilastatin- and imipenem- and relebactam-containing product in parenteral dose form Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start